Titre:
  • Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study
Auteur:Sitbon, Olivier; Sahay, Sandeep; Escribano Subias, Pilar; Zolty, Ronald R.L.; Kingrey, John J.F.; Ryan, John; Sobol, Irina; Sood, Namita; Benza, Raymond L.; Channick, Richard N.; Chin, Kelly Marie; Frantz, Robert R.P.; Ghofrani, Hossein Ardeschir; Hemnes, Anna Ryan; McLaughlin, Vallerie; Vachiery, Jean-Luc; Zamanian, Roham R.T.; ter Veer, Anna; Roscigno, Robert R.F.; Mottola, David; Parsley, Ed; Aranda, Richard; Zisman, Lawrence L.S.; Howard, Luke
Informations sur la publication:Advances in therapy, 42, 10, page (5104-5123)
Statut de publication:Publié, 2025-10
Sujet CREF:Pharmacologie
Sciences bio-médicales et agricoles
Mots-clés:Efficacy
Inhaled tyrosine kinase inhibitor
Long-term
PDGFR inhibitor
Pulmonary arterial hypertension
Pulmonary vascular resistance
Safety
Seralutinib
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0741-238X
info:doi/10.1007/s12325-025-03297-2
info:scp/105014404367
info:pmid/40788460